window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : December 6, 2025

  • News
  • About Us
Contact Us

antibody-drug conjugates

  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology

    Ona Therapeutics appoints Antoine Yver as chair to steer ADC pipeline into clinical development

    Ona Therapeutics has appointed Antoine Yver as chair of its [...]

    November 19, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,Peptides,Research & Development

    Solvias CSO Danny Galbraith on peptides, ADCs and AI driving drug development innovation

    Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

    November 7, 2025
  • Biotech,Oncology,Partnerships & Funding,Research & Development

    Myricx Bio appoints Boston-based Mohit Rawat as CEO and expands team in US and UK

    Myricx Bio has appointed Boston-based Mohit Rawat as chief executive [...]

    October 6, 2025
  • Biologics & Biosimilars,Biotech,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Synaffix and Qurient partner on dual-payload ADC for solid tumours

    Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]

    September 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Development,Regulatory Affairs,Supply Chain & Logistics

    Symbiosis completes 1,000th batch of sterile injectable drug product

    Contract manufacturer Symbiosis Pharmaceutical Services has announced the completion of [...]

    July 31, 2025
  • Artificial Intelligence,Market Access & Commercialization,Oncology

    Caris CMO on AI, equity, and the future of multi-omic oncology

    The former ASCO president shares his insights on breast cancer [...]

    July 4, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Development,Movers & Shakers,Partnerships & Funding

    Abzena forms Scientific Advisory Board to guide innovation in complex biologics

    Abzena, an integrated CDMO and CRO specializing in complex biologics [...]

    May 19, 2025
  • Drug Development

    SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges

    SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

    May 6, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme
    Categories: Central Nervous System, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
  • Horiba UK launches philanthropic foundation to advance scientific research and broaden STEM participation
    Categories: Facilities and infrastructure, Healthcare leadership, Research & Development
  • Net-zero in action: ABB powers GSK’s sustainability leap in Singapore
    Categories: CDMOs & Manufacturing, Market Access & Commercialization, Sustainability
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top